Client News

Secarna Pharmaceuticals Publishes New Data in Nucleic Acid Therapeutics Showcasing Strategies to Detect and Prevent Immunostimulatory Potential of LNA-Modified ASOs

New Nature Publication Confirms CARBIOS’ Leadership in Enzymatic Degradation of Plastic

invIOs Selects INV501 Lead Candidate to Progress into IND-Enabling Studies in Glioblastoma and Melanoma

Abivax Provides Operational and Key Program Update

Andera Partners’ Portfolio Company Amolyt Pharma Completes Acquisition by AstraZeneca

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Affluent Medical Announces the Availability of a Prospectus for the Admission to Trading of 6,190,831 Shares Issued as Part of a Capital Increase without Preferential Subscription Rights in Favour of a Category of Beneficiaries

Affluent Medical Signs Agreements for Mitral Valve Technologies with EUR 15M Upfront Payment

Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational

HepaRegeniX Raises €15 Million Series C Round to Advance Clinical Development of HRX-215 for Liver Regeneration